| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 34,325 | 31,472 | 44,823 | 34,231 | | Cost of Revenue | 11,723 | 13,685 | 17,359 | 14,056 | | | Gross Profit | 22,602 | 17,787 | 27,464 | 20,175 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 20,518 | 18,451 | 22,096 | 21,482 | | Non Recurring | 1,416 | 1,130 | 2,918 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 668 | (1,794) | 2,450 | (1,307) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3 | 247 | 39 | 456 | | Earnings Before Interest And Taxes | 671 | (1,547) | 2,489 | (851) | | Interest Expense | 136 | 216 | 329 | 733 | | Income Before Tax | 535 | (1,763) | 2,160 | (1,584) | | Income Tax Expense | 391 | (179) | 300 | 301 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 144 | (1,584) | 1,860 | (1,885) | | | Non-recurring Events | | Discontinued Operations | (376) | (222) | 878 | 1,051 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (232) | (1,806) | 2,738 | (834) | | Preferred Stock And Other Adjustments | (1,252) | (1,208) | (1,207) | (1,206) | | | Net Income Applicable To Common Shares | ($1,484) | ($3,014) | $1,531 | ($2,040) |
|
0.51% Nasdaq 
Income Statement
